(79.5% versus 53.5% and 40%, respectively). Only 20.5% of the isolates were susceptible to all quinolones, and ciprofloxacin was active against 31.5% of the strains. Fosfomycin was frequently active, with a resistance rate of 7%.
Characterization of ESBLs. Seventeen ESBL types were identified among the 200 isolates studied (Fig. 2a) . The CTX-M type was the most prevalent (90%). The three major CTX-M variants were CTX-M-15 (46.5%), CTX-M-1 (15.5%), and CTX-M-14 (15%). Nine other CTX-M enzymes were observed in 0.5% to 4.5% of the isolates as follows: CTX-M-27 (4.5%), CTX-M-9 (2.5%), CTX-M-3 (2.5%), CTX-M-24 (1.5%), CTX-M-32 (1.5%), CTX-M-57 (1.5%), CTX-M-55 (0.5%), CTX-M-65 (0.5%), and the novel CTX-M-139 (0.5%), which had derived from CTX-M-15 by the Y27F substitution. SHV-and TEM-type ESBLs were observed in 8% (SHV-12, n ϭ 16) and 3.5% (TEM-7, n ϭ 1; TEM-92, n ϭ 1; TEM-52, n ϭ 1; TEM-24, n ϭ 4) of the strains. Eight strains produced two ESBLs.
The distributions of ESBLs were different in the three major species (Fig. 2b) . CTX-M-1 and CTX-M-14 were frequently observed in E. coli strains (24.2% and 21.8% versus 37.1% for CTX-M-15) but were rare in K. pneumoniae, which mainly produced CTX-M-15 (81.1%). CTX-M-15 and SHV-12 were the main ESBLs in E. cloacae (51.7% and 37.9%, respectively). No carbapenemase was observed among the eight isolates intermediate or resistant to ertapenem (five E. cloacae isolates, two K. pneumoniae isolates, and one E. aerogenes isolate).
No plasmid-encoded AmpC was detected among the 200 strains. OXA-1 was detected in 41% of the strains and was especially associated with CTX-M-15 (84%).
Plasmid-borne genes encoding resistance to quinolones and aminoglycosides. The genes encoding the aminoglycoside acetyltransferases AAC(6=)-Ib and AAC(3)-II were identified in 45% and 37.5% of the isolates, respectively (Fig. 3a) . The gene encoding methylase RmtB was detected in only one isolate. The aac(6=)-Ib-cr and qnrB-type genes were the most frequent plasmid-mediated quinolone resistance genes (38.5% and 19.5%). The qnrA1, qnrS1, and qepA genes were more uncommon (3%, 5.5%, and 0.5%, respectively). Among the qnrB variants, the B1 allele was the most frequent (68.4%), with the prevalence of other B alleles ranging from 2.6% to 7.9% (Fig. 3a) . AAC(6=)-Ib-cr, AAC(3)-II, and QnrB were mainly associated with ESBLs CTX-M-15 (74.1%, 63.4%, and 29%, respectively) and SHV-12 (18.75%, 31.25%, and 50%, respectively) ( Fig. 3b) . QnrA1 was observed only in SHV-12-producing strains (31.25%) (Fig. 3b) . No qnrC, qnrD, oqx, or mcr-1 genes were detected.
Analysis of clonal relatedness. Among the 124 E. coli isolates, 56 clusters were identified by repetitive sequence-based PCR (rep-PCR) ( Fig. 4a and b ; see also Fig. S1 in the supplemental material). The largest cluster comprised 27 of the 30 isolates belonging to ST131 (90%). They were isolated in 12 different hospitals, with 1 to 4 isolates per hospital: 1 isolate for 3 hospitals, 2 isolates for 4 hospitals, 3 isolates for 4 hospitals, and 4 isolates for 1 hospital. Among the other strains, 62 were classified in 20 clusters comprising 2 to 7 isolates as follows: 2 isolates (n ϭ 10 clusters), 3 isolates (n ϭ 4 clusters), 4 isolates (n ϭ 3 clusters), 5 isolates (n ϭ 1 cluster), 6 isolates (n ϭ 1 cluster), and 7 isolates (n ϭ 1 cluster). Only four were isolated from two different patients in a single hospital. Twenty-six clusters were identified among the 37 K. pneumoniae isolates (Fig. 4c) . They contained 1 to 6 isolates as follows: 1 isolate (n ϭ 21 clusters), 2 isolates (n ϭ 3 clusters), 4 isolates (n ϭ 1 cluster), and 6 isolates (n ϭ 1 cluster). The five clusters of 2 to 6 isolates comprised only CTX-M-15-producing ones, and all of them were isolated from 2 (n ϭ 4) to 4 (n ϭ 1) patients in a single hospital. The 10 strains of the clusters of 6 and 4 isolates belonged to closely related sequence types ST395, ST1884, and ST2461.
Sixteen clusters were identified among the 29 E. cloacae strains (Fig. 4d) . They comprised 1 to 5 isolates as follows: 1 isolate (n ϭ 11), 2 isolates (n ϭ 2), 4 isolates (n ϭ 1), and 5 isolates (n ϭ 2). Four of them were isolated from 2 (n ϭ 3) to 3 (n ϭ 1) patients in a single hospital.
Overall, these data reveal a broad diversity of ESBL-producing Enterobacteriaceae isolates, including the species K. pneumoniae and E. cloacae.
Virulence factor (VF)-encoding genes and E. coli phylogroups. A total of 33% of E. coli isolates belonged to the B2 phylogroup; 73.1% were ST131isolates. Phylogroups C (17.7%), D (17.7%), and A (15.4%) had similar prevalences. The other phylogroups were more uncommon (F, 9.7%; B1, 5.6%; and B2 1 , 0.8%).
Among the E. coli VF-encoding genes investigated, iron-chelating VFs were the most frequent (fyuA, 79%; iucC, 66%; iroN, 33%), followed by the hra gene (41%) and the papC pilus-encoding gene (35%). The prevalence of the others ranged from 8% to 19% (Fig.  5a ). Most E. coli isolates harbored fewer than four VF genes (66.1%). As expected, VFs were more frequent in isolates belonging to B2 phylogroup ( Fig. 5c ): 43.9% harbored at least five VFs, but few of those belonged to highly prevalent sequence type ST131. ST131 isolates harbored a variable number of VFs ranging from 1 to 9. Of those isolates, 60% (n ϭ 18/30) produced only yersiniabactin and aerobactin, and only 30% harbored at least five VFs and. On the basis of DiversiLab clusters and VFs, two ST131 major groups can be individualized (Fig. 5d) . One group comprised 17 isolates that produced only yersiniabactin and aerobactin. The second comprised 6 isolates that produced 7 virulence factors.
Very few VF genes were detected in the K. pneumoniae strains (Fig. 5b) . None of those strains belonged to the K1 or K2 serotype, harbored the rmpA or rmpA2 gene, or accumulated siderophore-encoding genes, which are observed in strains responsible for invasive infections (3). The main VFs were the adhesion-encoding genes fimH and mrkD (100%), wagG (100%), and uge (97.3%). The other genes, kfu and allS, were observed in 27% and 5.4% of K. pneumoniae isolates, respectively.
ESBL-encoding plasmids. We obtained transformants or transconjuguants harboring only one plasmid for 81 strains. The presence of the ESBL gene on the plasmid was confirmed by Southern blotting.
We studied the plasmid content of the isolates (Table 1) harboring the most prevalent ESBLs in E. coli (CTX-M-15, n ϭ 10; CTX-M-1, n ϭ 10; CTX-M-14, n ϭ 10), K. pneumoniae (CTX-M-15, n ϭ 28), and E. cloacae (CTX-M-15, n ϭ 12; SHV-12, n ϭ 11).
Among the K. pneumoniae isolates, CTX-M-15 was mainly encoded by plasmids belonging to the FIIK (n ϭ 23/28; size, 160 to 170 kb) and R (n ϭ 5/28; size, 70 or 140 kb) incompatibility groups. Most FIIK plasmids belonged to the FIIK:7 subtype (n ϭ . bla CTX-M-14 was observed on 40-to 120-kb IncF plasmids F2:A-:B-(n ϭ 4/10), F24:A-:B1 (n ϭ 1/10), F47:A-B-(n ϭ 1/10), F1:A2:B20 (n ϭ 1/10), F1:A6:B20 (n ϭ 1/10), and F-:A6:B-(n ϭ 1/10) and on a 90-kb IncL/M K plasmid (n ϭ 1/10). Less diversity was observed for bla CTX-M-1 , which was carried on I1:3 plasmids (n ϭ 8/10; size, 90 to 120 kb), an FII:47 plasmid (n ϭ 1; size, 62 kb), and an X1 plasmid (n ϭ 1; size, 50 kb).
DISCUSSION
The aim of our study was to identify the ESBLs produced by the Enterobacteriaceae isolates responsible for infections and the mechanisms associated with their spread at the national level. The annual prevalence measures of ESBLs in Enterobacteriaceae and E. coli ranged between 3% and 10%. E. coli was the main species isolated (62%), and most of the isolates were collected from urinary tract samples (68%), as described in previous studies (1, 2) . Although their frequency was lower than 10% in most of the participating hospitals, the prevalence of ESBL-producing K. pneumoniae and Enterobacter strains was worrying in certain centers that had prevalence values (Ͼ20%) similar to those observed during the early 1990s in most French hospitals (1) . Most of the isolates were susceptible to fosfomycin (93%) and carbapenems (96% to 99.5%). Cefoxitin and the piperacillin-tazobactam association were inconstantly active (83% and 76.5%).
The main ESBLs characterized during this study belonged, as expected, to the CTX-M family. The three ESBLs CTX-M-15 (46.5%), CTX-M-1 (15.5%), and CTX-M-14 (15%) (5) . In contrast to a previous study (6), we observed a higher prevalence of qnrB than qnrA. No carbapenemases were observed, and only one isolate harbored a 16S methytransferase-encoding gene (rmtB). These results give an overview of the diffusion of major plasmid-encoded resistance associated with bla ESBL and the wide diffusion of aac(6=)-Ib-cr and qnr in ESBL-producing strains. Clonal-relatedness analysis and characterization of incompatibility groups of ESBLencoding plasmids revealed different species-specific rates of ESBL diffusion.
A wider diversity of ESBL was observed among E. coli strains (14 different ESBLs), with 3 major groups producing CTX-M-15 (47/124), CTX-M-1 (28/124), and CTX-M-14 (27/124). DiversiLab analysis identified only 56 clonal clusters for 124 isolates with a major ST131 cluster (30 isolates). However, the analysis of VFs, ESBL content, and other resistance mechanisms revealed only three pairs of identical ST131 isolates. These results suggest that the ST131 clone is endemic in France and has evolved in many different ways (acquisition of different virulence factors, ESBLs, and plasmid-encoded resistance mechanisms), forming different variants that cannot be discriminated by the usual molecular typing methods such as rep-PCR. A whole-genome comparison of these strains would be useful to improve discriminatory ability. Moreover, plasmid analysis of CTX-M-1-, CTX-M-14-, and CTX-M-15-encoding plasmids showed a broadest diversity of plasmids (incompatibility groups I1, FIA, FIA-FIB, FIB, and FII), especially for those harboring bla CTX-M- 15 and bla CTX-M-14 . These results suggest that the diffusion of CTX-M-15 and CTX-M-14 among E. coli strains in France was not linked to the diffusion of a major epidemic plasmid as suggested by previous studies (7) and suggest very active transfers of CTX-M-15-encoding genes in different plasmids in this species. In contrast, an association was observed between bla CTX-M-1 and I1:3 plasmids of similar sizes. We also observed a strong association of the IncI1 plasmid with the CTX-M-1-encoding gene as previously observed in animal and human strains (7). Among K. pneumoniae isolates, only 6 different ESBLs, with the great majority being CTX-M-15 (30/37), were identified. DiversiLab analysis revealed a wide diversity of strains of this species (26 clonal clusters for 37 isolates). In contrast to what was observed in E. coli, plasmid analysis identified a strong association of CTX-M-15-encoding plasmids belonging to FIIK and R in K. pneumoniae strains.
ESBL diversity was also low among the E. cloacae isolates, with only 6 different ESBLs representing a great majority of CTX-M-15 (15/29) and SHV-12 (11/27). Clonal diversity was lower in this species, with only 16 clonal clusters identified by DiversiLab analysis among 29 isolates. In this species, bla SHV-12 and bla CTX-M-15 were associated with plasmids belonging to the HI2 and Y incompatibility groups. Moreover, comparisons of plasmid sizes suggested the diffusion of very similar plasmids.
Our findings also indicate that ESBL-encoding plasmids are somewhat species specific. The same bla ESBL gene was observed in different plasmids in different species, suggesting that bla ESBL has to transfer into a plasmid adapted to the bacterial host to achieve epidemiological success. The relationship between species and plasmid seems to be a strong functional constraint on bacteria evolution and could explain the lack of epidemiological success of certain resistance mechanisms. The epidemiology of ESBLs may therefore not be directly related between species: the relationship between the plasmids and the bacterial species could explain the differences in ESBL prevalence observed according to the Enterobacteriaceae species.
Overall, the ESBL-producing isolates produced a small number of virulence factors. Iron-chelating factors were the most frequently observed factors in these two species, probably because of their major role in bacterial viability in the human body. Most E. coli ST131 isolates harbored fewer than five virulence factors (70%), suggesting a current rare association of ESBL plasmids with highly virulent strains.
In conclusion, our report gives an overview of the main characteristics of French ESBL-producing Enterobacteriaceae strains (main resistance mechanisms, clonal diffusion, plasmid diffusion, and virulence). It confirms the diffusion of the three major CTX-M-enzymes CTX-M-15, CTX-M-1, and CTX-M-14 and identifies the plasmids as major actors in ESBL spread.
MATERIALS AND METHODS
Clinical isolates. Between June 2012 and October 2012, consecutive, nonrepetitive ESBL-producing Enterobacteriaceae strains isolated from clinical samples of inpatients and outpatients were collected in 18 representative French hospitals (15 teaching hospitals and 3 nonteaching public hospitals) spread over the entire French territory. All species of Enterobacteriaceae were included, and ESBL production was confirmed in each participating center according to the recommendations of the Antimicrobial Committee of the French Society for Microbiology (CA-SFM) (8) . Screening samples, such as rectal swabs, were excluded. Between 7 and 17 strains were collected from each participating center according to size. All the strains were sent to the French National Reference Centre for antibiotic resistance for further investigations (Gabriel Montpied Hospital, Clermont-Ferrand, France). Virulence studies of E. coli strains were performed by the French National Reference Centre for E. coli (Robert-Debré Hospital, Paris, France).
Antimicrobial susceptibility testing and ESBL detection. Identification of strains was confirmed by the Vitek matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) method (bioMérieux, La Balme, France). The production of ESBL was detected according to the recommendations of the Antimicrobial Committee of the French Society for Microbiology (CA-SFM) (8) . Antibiotic susceptibilities were determined by the disk diffusion method according to the CA-SFM recommendations (8) . ESBL production was confirmed by the double-disk synergy test (8) . The following 18 antibiotics were tested: amoxicillin, amoxicillin-clavulanic acid, ticarcillin, piperacillin-tazobactam, cephalothin, cefoxitin, ceftazidime, cefotaxime, ertapenem, imipenem, amikacin, gentamicin, tobramycin, nalidixic acid, ofloxacin, ciprofloxacin, fosfomycin, and co-trimoxazole (Bio-Rad, Marnes-La-Coquette, France).
Characterization of ␤-lactamase-encoding genes and associated resistance genes. ␤-Lactamases were investigated by isoelectric focusing as previously described (9) . The ESBL-encoding genes were identified by specific PCR and sequencing experiments using specific primers as described elsewhere (9) . Carbapenemase production was investigated in carbapenem-resistant strains by specific PCR as previously described (10) . Genes encoding AAC(6=)-Ib, AAC(6=)-Ib-cr, AAC(3)-II, RmtA to RmtH, ArmA, NpmA, QnrA, QnrB, QnrC, QnrD, QnrS, Oqx (for strains not belonging to the Klebsiella genus), and QepA were identified by specific PCR assay and sequencing as previously reported (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Plasmidmediated colistin resistance mechanism MCR-1 was investigated as previously described (22) . Plasmidencoded AmpC and OXA-1 production was investigated as previously described (23, 24) .
Molecular strain typing.
The relatedness between ESBL-producing isolates was assessed by repetitive sequence-based PCR (rep-PCR) using the DiversiLab method according to the manufacturer's instructions (bioMérieux, La Balme, France). The analysis was performed using Pearson's correlation in the dedicated DL software of the manufacturer (version 3.6). Isolates with similarities of Ͻ95% were considered different, and isolates with similarities of Ͼ98% were considered indistinguishable. All isolates with similarities of Ͼ95% and Ͻ98% were judged manually using the pattern overlay of the analysis tool in the software (25) . A Pearson distance matrix was calculated using DiversiLab, and classical multidimensional scaling was then performed on the distance matrix using R to illustrate the relationship between the isolates (26) . The phylogroup of E. coli strains (A, B1, B2, C, D, E, or F) was determined by a PCR method as previously described (27) . The highly virulent B2 1 subgroup was also identified by specific PCR (28). O25b-ST131 E. coli clones were identified according to the PCR method described by Clermont et al. (29) . MLST for K. pneumoniae isolates was performed as previously described by Diancourt et al. (30) .
Analysis of ESBL-encoding plasmids. Transferability of the ESBL-encoding genes was studied by mating-out assay. When these experiments failed, plasmid DNA was extracted with NucleoBond Xtra (Macherey-Nagel, Germany) and transferred by electroporation into an E. coli K-12 recipient. Selection was performed on agar plates supplemented with ceftazidime or cefotaxime (4 mg/liter) and rifampin (300 mg/liter) for the mating-out assay and ceftazidime or cefotaxime (4 mg/liter) for electroporation. The size of ESBL-encoding plasmids was determined by Southern blotting with ESBL-specific probes using plasmid DNA extracted by the method of Kado and Liu (31) with plasmids Rsa (39 kb), TP114 (61 kb), pCFF04 (85 kb), and pCFF14 (180 kb) used as standards. The plasmid content of transconjugants or transformants containing one plasmid was further studied by PCR-based replicon typing (PBRT) and plasmid multilocus sequence typing (MLST) (32, 33) .
Characterization of virulence factor-encoding genes. The following 11 virulence factor-encoding genes of extraintestinal pathogenic E. coli (ExPEC) strains were identified by multiplex PCR, as previously described (34) : papC (encoding outer membrane usher protein PAPC), papGII and papGIII (P fimbriae), sfa and foc (sfa/foc) (S fimbriae), hlyC (hemolysin), cnf1 (cytotoxic necrotizing factor), iucC (aerobactin), fyuA (yersiniabactin), iroN (salmochelin), hek/hra (hemagglutinin), and ibeA (endothelial invasin). For K. pneumoniae isolates, 9 genes (uge, mrkD, fimH, allS, rmpA, magA, wabG, kfu, and cf29a) were screened by PCR assays (3). Capsule csp-based genotyping was performed as previously described (35) . Strains NTUH-K2044, KP52145, and MGH 78578 were used as PCR controls.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/ AAC.01911-16.
TEXT S1, PDF file, 0.1 MB.
